Skip to main content

Table 2 Clinical long-term parameters

From: Long-term implications of structured transition of adolescents with inflammatory bowel disease into adult health care: a retrospective study

 

Transfer (n = 11)

Transition (n = 24)

p-value

Patients with at least one IBD-related intestinal complication, n (%)

7 (64%)

5 (21%)

0.022*

Patients with at least one IBD-related surgery, n (%)

5 (46%)

3 (13%)

0.077*

Number of IBD-related hospitalizations, n (range)

3 (0–11)

1 (0–3)

0.112#

Height Z-score at the age of eighteen

  

0.854+

 -2 < Z, n (%)

1 (9%)

1 (4%)

 

 -2 ≤ Z ≤ 0, n (%)

6 (55%)

13 (54%)

 

 0 < Z ≤ 2, n (%)

4 (36%)

9 (38%)

 

 Z > 2, n (%)

0 (0%)

1 (4%)

 

Height Z-score at the age of eighteen

−0.54 (±1.26)

−0.10 (±1.22)

0.328^

BMI Z-score at the age of eighteen

  

0.265+

 -2 < Z, n (%)

2 (18%)

2 (8%)

 

 -2 ≤ Z ≤ 0, n (%)

7 (64%)

11 (46%)

 

 0 < Z ≤ 2, n (%)

2 (18%)

11 (46%)

 

 Z > 2, n (%)

0 (0%)

0 (0%)

 

BMI Z-score at the age of eighteen

−0.56 (±1.22)

−0.25 (±1.02)

0.441^

Patients with documented pubertal delay, n (%)

3 (27%)

0 (0%)

0.025*

Patients with a psychiatric disorder diagnosed within the study period, n (%)

4 (36%)

3 (13%)

0.171*

Cumulated doses of radiation in mSv

4.2 (±5.3)

0.01 (±0.01)

0.036#

Patients with at least one adverse effect caused by IBD medication, n (%)

6 (55%)

12 (50%)

1.000*

  1. Legend. IBD, inflammatory bowel disease; BMI, body mass index; mSV, millisieverts; *Fisher’s exact test; +Chi-square test; #Mann-Whitney U test; ^2-sample t test